Literature DB >> 24668789

Ending vertical transmission of hepatitis B: the third trimester intervention.

Monika Sarkar1, Norah A Terrault.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24668789      PMCID： PMC5938736          DOI： 10.1002/hep.27145

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  18 in total

1.  Chronic hepatitis B: update 2009.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

2.  Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.

Authors:  Mustafa Kemal Celen; Duygu Mert; Müzeyyen Ay; Tuba Dal; Safak Kaya; Necmettin Yildirim; Serda Gulsun; Tunga Barcin; Sevgi Kalkanli; Mehmet Sinan Dal; Celal Ayaz
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 3.  Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China.

Authors:  G B Yao
Journal:  Gut       Date:  1996       Impact factor: 23.059

4.  Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series.

Authors:  Calvin Q Pan; Li-Jun Mi; Chalermrat Bunchorntavakul; Jeffrey Karsdon; William M Huang; Gaurav Singhvi; Marc G Ghany; K Rajender Reddy
Journal:  Dig Dis Sci       Date:  2012-04-29       Impact factor: 3.199

Review 5.  Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis.

Authors:  Chuanfang Lee; Yan Gong; Jesper Brok; Elizabeth H Boxall; Christian Gluud
Journal:  BMJ       Date:  2006-01-27

6.  Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.

Authors:  Yun-Fan Liaw; Jia-Horng Kao; Teerha Piratvisuth; Henry Lik Yuen Chan; Rong-Nan Chien; Chun-Jen Liu; Ed Gane; Stephen Locarnini; Seng-Gee Lim; Kwang-Hyub Han; Deepak Amarapurkar; Graham Cooksley; Wasim Jafri; Rosmawati Mohamed; Jin-Lin Hou; Wan-Long Chuang; Laurentius A Lesmana; Jose D Sollano; Dong-Jin Suh; Masao Omata
Journal:  Hepatol Int       Date:  2012-05-17       Impact factor: 6.047

7.  A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.

Authors:  Lei Han; Hong-Wei Zhang; Jia-Xin Xie; Qi Zhang; Hong-Yang Wang; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

8.  Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations.

Authors:  A Ayres; L Yuen; K M Jackson; S Manoharan; A Glass; M Maley; W Yoo; S P Hong; S-O Kim; F Luciani; D S Bowden; J Bayliss; M T Levy; S A Locarnini
Journal:  J Viral Hepat       Date:  2013-12-11       Impact factor: 3.728

9.  Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study.

Authors:  Amanda H Corbett; Dumbani Kayira; Nicole R White; Nicole L Davis; Athena P Kourtis; Charles Chasela; Francis Martinson; Grace Phiri; Bonaface Musisi; Deborah Kamwendo; Michael G Hudgens; Mina C Hosseinipour; Julie Ae Nelson; Sascha R Ellington; Denise J Jamieson; Charles van der Horst; Angela Kashuba
Journal:  Antivir Ther       Date:  2014-01-24

10.  Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.

Authors:  Hua Zhang; Calvin Q Pan; Qiumei Pang; Ruihua Tian; Miaoe Yan; Xin Liu
Journal:  Hepatology       Date:  2014-08       Impact factor: 17.425
View more
  7 in total

Review 1.  Chronic hepatitis B infection in pregnancy.

Authors:  Jennifer R Lamberth; Sheila C Reddy; Jen-Jung Pan; Kevin J Dasher
Journal:  World J Hepatol       Date:  2015-05-28

2.  Prevalence of Hepatitis B and C Viral Infection Among Pregnant Women in Peshawar, Pakistan.

Authors:  Irshad Ahmad
Journal:  Hepat Mon       Date:  2016-06-01       Impact factor: 0.660

3.  Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update).

Authors:  Jinlin Hou; Guiqiang Wang; Fusheng Wang; Jun Cheng; Hong Ren; Hui Zhuang; Jian Sun; Lanjuan Li; Jie Li; Qinghua Meng; Jingmin Zhao; Zhongping Duan; Jidong Jia; Hong Tang; Jifang Sheng; Jie Peng; Fengmin Lu; Qing Xie; Lai Wei
Journal:  J Clin Transl Hepatol       Date:  2017-11-12

Review 4.  Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis.

Authors:  Marianna G Mavilia; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2017-06-07

5.  Clinical features of treatment-naive patients with hepatitis B virus infection: A community-based survey from high- and intermediate-hepatitis B endemicity regions in Southeast China.

Authors:  Wei Wu; Yu Zhu; Chenbo Yu; Shigui Yang; Bing Ruan; Yu Chen; Lanjuan Li
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

6.  Hepatitis B Virus Infection and Increased Risk of Gestational Diabetes Regardless of Liver Function Status: A Xiamen Area Population-Based Study.

Authors:  Min Zhao; Shuyu Yang; Xiaojie Su; Tzu-Chieh Hung; Yishan Liu; Wenjie Zheng
Journal:  Front Physiol       Date:  2022-07-11       Impact factor: 4.755

7.  Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China.

Authors:  Qiuju Sheng; Yang Ding; Baijun Li; Chao Han; Yanwei Li; Chong Zhang; Han Bai; Jingyan Wang; Lianrong Zhao; Tingting Xia; Ziying An; Mingxiang Zhang; Xiaoguang Dou
Journal:  Int J Med Sci       Date:  2018-05-22       Impact factor: 3.738
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.